Overview
- Editors:
-
-
Donald H. Gilden
-
Department of Neurology, University of Colorado Health Sciences Center, Denver, USA
-
Howard L. Lipton
-
Department of Neurology, Northwestern University Medical School, Chicago, USA
Access this book
Other ways to access
Table of contents (18 chapters)
-
-
- D. W. Trent, J. T. Roehrig, T. F. Tsai
Pages 1-41
-
- Francisco Gonzalez-Scarano, Neal Nathanson
Pages 43-68
-
-
- Ehud Lavi, Susan R. Weiss
Pages 101-139
-
- Daniel C. Pevear, Charles J. Pfau
Pages 141-172
-
-
- T. R. Moench, R. T. Johnson
Pages 203-229
-
-
- Miriam Calenoff, Burk Jubelt, Howard L. Lipton
Pages 245-268
-
- W. H. Wunner, H. Koprowski
Pages 269-302
-
- Betty L. Slagle, Jerry S. Wolinsky
Pages 303-318
-
-
- William G. Stroop, J. Richard Baringer
Pages 343-367
-
- Abbas Vafai, Donald H. Gilden, Zofia Wroblewska
Pages 369-391
-
- P. G. E. Kennedy, O. Narayan, M. C. Zink, Jay Hess, J. Clements, R. J. Adams
Pages 393-421
-
- Stanley B. Prusiner, Karen K. Hsiao, Dale E. Bredesen, David T. Kingsbury
Pages 423-467
-
- Henry F. McFarland, Steven Jacobson
Pages 469-499
-
- Diane E. Griffin, Thiravat Hemachudha, Richard T. Johnson
Pages 501-527
-
Back Matter
Pages 529-543
About this book
In the summer of 1984, both of us were working with Professor Yechiel Becker in the Laboratory for Molecular Virology at the Hebrew University-Hadassah Medical center in Jerusalem. During a discussion about the increasing number of specialized journals and monographs, Dr. Becker pointed out that none covered both the clinical and molecular aspects of neurotropic virus infections, and he urged us to develop such a book with the help of colleagues who were conducting highly-regarded research in their individual areas related to neurotropic viruses. The responses to our request were gratifying, and each contribution provided both a comprehensive clinical description of the neurologic disease produced by a specific virus and an up-to-date review of the current research in the pathogenesis of the disease, with particular attention given to molecular mechanisms. Most, but not all chapters were written by clinical neurologists who applied basic science strategies and methodologies to the question of how neurotropic viruses produce disease. other chapters were written by virologists known for their longstanding commitment and expertise in the analysis of the pathogenesis of neurotropic virus infections. Thus, this unique monograph should be valuable to all clinicians caring for patients with CNS viral diseases and to "neurovirologists" needing an update of the clinical and molecular pathogenesis of neurotropic virus infections. While this monograph was being prepared, a rapidly expanding literature indicated that the human lenteviruses, human immunodeficiency viruses (HIV) and HTLV-1 were highly neurotropic.
Editors and Affiliations
-
Department of Neurology, University of Colorado Health Sciences Center, Denver, USA
Donald H. Gilden
-
Department of Neurology, Northwestern University Medical School, Chicago, USA
Howard L. Lipton
